Gráfico del Precio de Acciones ENTX
ENTX Dividendos
Entera Bio Ltd
$2.81
-2.09%
$-0.06
Al cierre: Aug 05, 16:00:00 GMT-4
$2.79
-0.71%
$-0.02
Mercado Previo: Aug 06, 08:20:17 GMT-4
Atrás
Entera Bio Ltd (ENTX) Dividendos
Estadísticas clave
Cierre Anterior
$2.87
Precio de apertura
$2.84
Rango del día
$2.7 - $2.84
Rango de 52 semanas
$0.91 - $3.22
Volumen
308.4K
Volumen promedio
771.0K
Rendimiento de dividendos
--
EPS (TTM)
-0.26
Cap. de mercado
$137.5M
¿Qué es ENTX?
Entera Bio Ltd. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of orally delivered large molecule therapeutics. The firm developed a platform that enables the oral delivery of injectable proteins and large molecules. Entera Bio candidates are EB613 for the treatment of osteoporosis and EB612 for the treatment of hypoparathyroidism. Both EB613 and EB612 are oral formulations of human parathyroid hormone (1-34), or Parathormon (PTH). The products are administered via injection.
Características
© 2026 Edgen impulsado por
